(Reuters) Omega Advisors sold its stake in Valeant Pharmaceuticals International Inc (VRX.TO) in recent weeks after buying more shares during the third quarter, the hedge fund’s vice chairman said on Monday.
“We are no longer in Valeant,” Steven Einhorn said at the Reuters Global Investment Outlook Summit in New York. “We sold at higher prices.” He did not say exactly when Omega exited its position.
